Medicines Related problems on Admission to Hospital -The Evidence
|
|
- Harry Miller
- 6 years ago
- Views:
Transcription
1 East & outh East England pecialist harmacy ervices East of England, London, outh Central & outh East Coast Medicines Use and afety Medicines Related problems on Admission to Hospital -The Evidence In this document we review the evidence for adverse drug events (ADEs) leading to patients being admitted to hospital, consider the different causes of ADEs and highlight the difficulties in establishing an accurate estimate of the scale of the problem. Key points Drug related problems or adverse drug events can cause serious harm to patients and can lead to hospitalisation or even death ay attention to terminology used in literature: There are several causes of adverse drug events (ADEs); adverse drug reactions (ADRs) are one cause Rates of drug related hospital admissions quoted in literature vary widely (from 0.1% to 45%) due to variation in the study methodology from which they have been derived. A great deal of caution should be applied if extrapolating national hospital admission data or the prevalence identified by pooling international studies Clinical coding captures some ADRs, but is generally an underestimate. Coding will not capture ADEs Not all ADEs or ADRs are preventable. reventable drug related admission (DRA) rates reported in literature vary from 1.4%-15.4% (median 3.7%) Drugs most commonly associated with DRAs are anti-platelets, diuretics, NAIDs and anti-coagulants DRAs are most commonly associated with problems in adherence to, and prescribing and monitoring of, medication The main causes of DRAs are failures in communication and knowledge Elderly patients with multiple co-morbidities receiving multiple medicines for longterm illness are prone to ADRs & are likely to be more susceptible to ADEs in general Technical solutions and single interventions targeted at one stage of the medication use process, although useful, are unlikely to be sufficient on their own in reducing DRAs. Interventions which target the human causes such as improving communication methods are also required Winner: Dressings, rescqi Innovation awards 2013; Winner: R harmaceutical Care Award 2013 Finalist: HJ atient safety in primary care award 2013; Winner: UKCA/Guild Conference Best oster award 2013
2 Medicines Use and afety Medicines Related problems on Admission to Hospital -The Evidence Background There is general agreement that medicine-related problems or adverse drug events (ADEs), defined as patient injury related to taking a drug, are responsible for an appreciable proportion of hospital admissions and that a substantial proportion of these problems are potentially preventable, however, gaining an understanding of the true size of this problem is problematical due to terminology and methodological differences employed in published studies. An ADE can arise from: adverse drug reactions (ADRs) i.e. unwanted or harmful effect of medication failure by the patient to take the medicine as intended, medication errors e.g. prescribing, dispensing or administration errors, inappropriate or over treatment being prescribed, failure to prescribe an indicated treatment medication discrepancies i.e. unexplained differences in documented medication regimens, particularly at transfer of care e.g. hospital admission & discharge What is the overall size of the problem? Leendertse (2010) reviewed 95 studies which reported a range of medication -related hospitalisations from 0.1% to 54%. A higher prevalence was found in the studies which examined all hospital admissions compared to studies examining only acute hospital admissions, in studies in the elderly population compared to children, and in studies examining ADEs compared to studies examining only ADRs. The method of data collection strongly influenced the findings; medical chart screening resulted in a higher prevalence of medication-related hospitalisation compared to database methodology or spontaneous reporting. Combined studies in Europe showed a lower prevalence of medication-related hospital admissions than those from other continents included in the study Medicines-Related Admissions to Hospitals-The Evidence Apr14 V2 (JW) 2
3 Medicines Use and afety Admissions related to Adverse Drug Reactions (ADR) A review of 25 studies (Kongkaew 2008) reported ADR prevalence rates between 0.16% and 15.7%, with an overall median of 5.3%. The authors suggest methodological differences are the main reason for the variance. Overall, higher rates were found in elderly patients who were likely to have been receiving multiple medications for longterm illness. Using hospital coding to study ADR related admissions In theory, ADRs are easier to measure than ADEs, because some ADRs can be captured by coding. Wu (2010) examined data from the Hospital Episode tatistics database for all English hospital admissions ( ) with a primary or secondary diagnosis of an ADR recorded. Between 1999 and 2008, there were 557,978 ADR-associated admissions, representing 0.9% of total hospital admissions. Over this period the annual number of ADRs increased by 76.8% (from 42,453 to 75,076), and in-hospital mortality rate increased by 10% (from 4.3% to 4.7%). However, some of this increase may be due to improved diagnostic coding. In 2008, there were 6,830,067 emergency admissions of which 75,076 (1.1%) were drug-related. How does this compare to other countries? A similar panish study (Carrasco-Garrido 2010) during the period , reported 1.69% hospitalised patients had a diagnostic code that was ADR related. Of these just over 5% died. The medicines most commonly associated with the admission were antineoplastic and immunosuppressive medicines, corticosteroids, anticoagulants and antibiotics. In the Netherlands, ADR related hospital admissions rates of 0.41% for men and 0.47% for women were reported during the period (Rodenburg 2011). A German record-based study which analysed patient records of 57,000 hospitalisations between estimated the incidence of hospitalisation due to possible serious outpatient ADRs to be approximately 3.25%. The mean age of patients was 71yrs and the most frequent ADRs were gastrointestinal haemorrhage and drug induced hyoglycaemia (Rottenkolber 2011). A Canadian study has suggested that a significant proportion of potential ADRs are not attributed to the medicine by doctors in the emergency department, and may be subsequently missed during the coding process (Hohl 2010). Relying on coding to capture ADR related admissions may underestimate the size of the problem. Medicines-Related Admissions to Hospitals-The Evidence Apr14 V2 (JW) 3
4 Medicines Use and afety reventable drug-related admissions (DRAs) to hospital How many ADRs are preventable? Not all ADRs are preventable. ome, although they may be well documented, are unpredictable and little can be done to prevent them. A study in two large Merseyside Hospitals (irohammed 2004) found that of 18,820 patients admitted to hospital over a six-month period, there were 1,225 admissions judged to be related to an ADR, giving a prevalence of 6.5%. In 80% of cases the ADR was judged to have led directly to the admission. 72% ADR-related admissions were judged to have been avoidable. The median bed stay was eight days, accounting for 4% of the hospital bed capacity. The projected annual cost of such admissions to the NH was 446 million. In a cross-sectional, observational study (Rogers 2009), conducted over 3 months on the medical admissions ward of a north London hospital records for 409 patients aged > or =65 years were screened. Of these 14% (95% CI 10.6, 17.4) had medication-related problems, 6.4% (95% CI 4.0, 8.8) were admitted because of medication-related problems and 3.9% (95% CI 2.0, 5.8) were considered to have preventable medication-related problems. Medicines to prevent or treat cardiovascular disease were implicated in 69% (18/26) of the medication-related admissions and 69% (11/16) of preventable medicationrelated admissions. Amongst hospitalized patients, admission attributed to adverse drug reaction was more likely as the number of medications being taken increased, and admission attributed to under treatment was more likely as the number of pre-existing conditions increased. A small study in one UK hospital (Davies 2010) reported that approximately one fifth of those patients readmitted to hospital within a year of discharge were re-admitted due to a suspected ADR and that over half of these (n=52/91; 57%) were judged to be definitely or possibly avoidable. In 30% (n=11/37) of patients readmitted within 28 days of discharge the causative drug had been initiated in during the index admission. A small Canadian study (ikdar 2010) reported that 29% (n=16 /55) of the ADRs or possible ADRs identified were considered preventable. In a further small UK study (Hodgson 2014) 56 patients were identified over a 5 month period as having a hospital admission related to an adverse drug reaction. In 35 patients (63%) the hospital admission was thought to be possible preventable. These studies all used retrospective case review, but differed in their sampling methodology. Medicines-Related Admissions to Hospitals-The Evidence Apr14 V2 (JW) 4
5 Medicines Use and afety Which drugs are associated with DRAs to hospital? A systematic review of 13 papers (Howard 2006) reported a median 3.7% rate (Range %) of DRAs to hospital. Admissions caused by ADRs, under or over treatment and medication adherence problems were included. From 9 papers, it was found that over 50% of DRAs involved four groups of drugs; anti-platelets (16%), diuretics (16%), NAIDs (11%) or anti-coagulants (8%). From five studies the median proportion of DRAs associated with prescribing problems was 30.6% (range ), with adherence problems 33.3% (range ) and with monitoring problems 22.2% (range ). What are the main causes of DRAs? A qualitative study of the causes of DRAs to a hospital in Nottingham from 4 CTs (Howard 2008) found that they were complex, multi-faceted and associated with problems at multiple stages in the medication use process, including prescribing, dispensing, administration, monitoring and help-seeking. The main causes of the problems were communication failures (between patients and healthcare professionals, and between groups of healthcare professionals) and knowledge gaps (about medicines and patients medical and medication history). It was concluded that solutions to the problems would need to take account of this complexity. Technical solutions and single interventions targeted at one stage of the medication use process, although useful, are unlikely to be sufficient on their own. Interventions which target the human causes such as improving communication methods are also required reventable deaths whilst in hospital Hogan (2012) carried out a retrospective case record review of 1000 adults who died in 10 acute hospitals in England. Death was considered to have a 50% or greater chance of being preventable in 5.2% of cases (95% CI 3.8% to 6.6%). roblems associated with preventable deaths occurred in all phases of hospital care and involved poor clinical monitoring (31%), diagnostic errors (30%) or inadequate drug or fluid management (21%). The majority of preventable deaths occurred in frail, elderly patients with multiple comorbidities judged to have less than 1 year of life left to live. Medicines-Related Admissions to Hospitals-The Evidence Apr14 V2 (JW) 5
6 Medicines Use and afety References Carrasco-Garrido, Lopez de Andres A, Hernandez-Barrera V, Gil de Miguel A, Jimenez-Garcia R.(2010). Trends of adverse drug reactions related-hospitalizations in pain ( ). BMC Health ervices Research;10:287 Davies EC, Green CF, Mottram DR, Rowe H, irmohamed M (2010). Emergency re-admissions to hospital due to adverse drug reactions within 1 year of the index admission. British Journal of Clinical harmacology ;70(5): Hodgson B, Wilcock M, Gibson N. Adverse Drug Reactions causing hospital admissions- helping Gs through shared learning. harmay Management 2014 ; 30(2); 3-6 Hogan H, Healey F, Neale G, Thomson R, Vincent C, Black N (2012). reventable deaths due to problems in care in English acute hospitals: a retrospective case record study. BMJ Quality & afety doi: /bmjqs Hohl CM, Zed J, Brubacher, Abu-Laban RB, Loewen, urssell RA (2010). Do emergency physicians attribute drug-related emergency department visits to medication-related problems? Annals of Emergency Medicine;55(6): Howard RL, Avery AJ, lavenburg, Royal, ipe G, Lucassen, irmohamed M (2006). Which drugs cause preventable admissions to hospital? A systematic review. Britich Journal of harmacology;63(2): Howard RL, Avery AJ, Bissell (2008). Causes of preventable drug-related hospital admissions: a qualitative study. Quality and afety in Health Care; 17(2): Kongkaew c, Noyce R, Ashcroft DM(2008). Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. Annals of harmacotherapy ;42(7-8) : Leendertse AJ, Visser D, Egberts ACG, van den Bemt MLA (2010). The relationship between study characteristics and the prevalence of medication-related hospitalizations: a literature review and novel analysis Drug afety;33(3): irohanned M, James, Meakin, Green C, cott AK, Walley TJ, Farrar K, ark BK, Breckenridge AM (2004). Adverse drug reactions as a cause of admission to hospital: prospective analysis of 18,820 patients. BMJ;329:15 Rogers, Wilson D, Wan, Griffin M, Rai G, Farrell J (2009). Medication-related admissions in older people: a cross-sectional, observational study. Drugs Aging;26(11) Rodenburg EM, tricker BHC, Visser LE (2011). ex-related differences in hospital admissions attributed to adverse drug reactions in the Netherlands. British Journal of Clinical harmacology;71(1): Rottenkolber D, chmiedl, Rottenkolber M, Farker K, et al (2011). Adverse drug reactions in Germany: direct costs of internal medicine hospitalizations. harmacoepidemiology and Drug afety ;20(6): ikdar KC, Alaghehbandan R, MacDonald D, et al. (2010). Adverse drug events in adult patients leading to emergency department visits. Annals of harmacotherapy;44(4): East & outh East England pecialist harmacy ervices Medicines-Related Admissions to Hospitals-The Evidence Apr14 V2 (JW) 6
Bulletin Independent prescribing information for NHS Wales
Bulletin Independent prescribing information for NHS Wales Medicines-related admissions February 2015 Although medicines play an important role in the management of chronic and acute illnesses, they can
More informationCommunity Intravenous Therapy Referral Standards
pecialist harmacy ervice Medicines Use and afety Community Intravenous Therapy Referral tandards Background A multi-centred audit of prescribing and administration of community IV therapy across East and
More informationExecutive Summary points to consider by organisations providing Primary and Community Health services
pecialist Pharmacy ervice Medicines Use and afety A ummary of Pharmacy upport required to deliver Medicines Optimisation in Primary Care based and Community Health ervices: A guide for Organisational Boards
More informationWhat are the potential ethical issues to be considered for the research participants and
What are the potential ethical issues to be considered for the research participants and researchers in the following types of studies? 1. Postal questionnaires 2. Focus groups 3. One to one qualitative
More informationSafer use of anticoagulants: the NPSA patient safety alert Steve Chaplin MSc, MRPharmS
Safer use of anticoagulants: the NPSA patient safety alert Steve Chaplin MSc, MRPharmS Steve Chaplin describes the NPSA s anticoagulant patient safety alert and the measures it recommends for making the
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE 1 Guideline title SCOPE Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes 1.1 Short title Medicines
More informationAppendix 1 MORTALITY GOVERNANCE POLICY
Appendix 1 MORTALITY GOVERNANCE POLICY 1 Policy Title: Executive Summary: Mortality Governance Policy For many people death under the care of the NHS is an inevitable outcome and they experience excellent
More informationNational clinical audit of inpatient care for adults with ulcerative colitis
National clinical audit of inpatient care for adults with ulcerative colitis UK inflammatory bowel disease (IBD) audit Executive summary report June 2014 Prepared by the Clinical Effectiveness and Evaluation
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Single Technology Appraisal (STA)
Thank you for agreeing to give us a statement on your organisation s view of the technology and the way it should be used in the NHS. Healthcare professionals can provide a unique perspective on the technology
More informationOmitted and Delayed Medicines
pecialist Pharmacy ervice Medicines Use and afety Omitted and Delayed Medicines A collaborative audit of omitted and delayed anti-microbial in acute, community and mental health settings Jane Hough and
More informationAdmissions and Readmissions Related to Adverse Events, NMCPHC-EDC-TR
Admissions and Readmissions Related to Adverse Events, 2007-2014 By Michael J. Hughes and Uzo Chukwuma December 2015 Approved for public release. Distribution is unlimited. The views expressed in this
More informationDirectorate Medical Operations Patients and Information Nursing Policy Commissioning Development
Review of National Reporting and Learning System (NRLS) incident data relating to discharge from acute and mental health trusts August 2014 NHS England INFORMATION READER BOX Directorate Medical Operations
More informationNational Early Warning Scoring System
National Early Warning Scoring System A common language for health care The deteriorating patient Professor Derek Bell January 2013 Adult National Early Warning Score Background Overview of NEWS Next Steps
More informationSMASH! 1 Introduction
SMASH! The Salford Medication Safety Dashboard 1 Introduction 1.1 Background A recent study of general practice identified errors in 5% of prescription items, with one in 550 items containing a severe
More informationOptimising Systems and Processes of Wound Care - A QIPP resource of good practice. Developing and Implementing a Wound Care Prescribing Policy
East & outh East England pecialist Pharmacy ervices East of England, London, outh Central & outh East Coast Medicines Use and afety Optimising ystems and Processes of Wound Care - A QIPP resource of good
More informationW e were aware that optimising medication management
207 QUALITY IMPROVEMENT REPORT Improving medication management for patients: the effect of a pharmacist on post-admission ward rounds M Fertleman, N Barnett, T Patel... See end of article for authors affiliations...
More informationIncreased mortality associated with week-end hospital admission: a case for expanded seven-day services?
Increased mortality associated with week-end hospital admission: a case for expanded seven-day services? Nick Freemantle, 1,2 Daniel Ray, 2,3,4 David Mcnulty, 2,3 David Rosser, 5 Simon Bennett 6, Bruce
More informationMedicines Optimisation: Helping patients to make the most of medicines
Medicines Optimisation: Helping patients to make the most of medicines Good practice guidance for healthcare professionals in England May 2013 Endorsed by Foreword The NHS Constitution establishes the
More informationFinal. Andrew McMylor / Dr Nicola Jones
NHS Standard Contract - Service Specification Service Specification Service Final 24hour Ambulatory Blood Pressure Monitoring (24hrABPM) Commissioner Lead Lead Andrew McMylor / Dr Nicola Jones Jeremy Fenwick,
More informationCase-mix Analysis Across Patient Populations and Boundaries: A Refined Classification System
Case-mix Analysis Across Patient Populations and Boundaries: A Refined Classification System Designed Specifically for International Quality and Performance Use A white paper by: Marc Berlinguet, MD, MPH
More informationKupu Taurangi Hauora o Aotearoa
Kupu Taurangi Hauora o Aotearoa National GTT Workshop 2014 Using Data for Improvement Update Global Trigger Tool (GTT) Targeted chart reviews using triggers as flags for patient harm Provides a high level
More informationNUTRITION SCREENING SURVEY IN THE UK AND REPUBLIC OF IRELAND IN 2010 A Report by the British Association for Parenteral and Enteral Nutrition (BAPEN)
NUTRITION SCREENING SURVEY IN THE UK AND REPUBLIC OF IRELAND IN 2010 A Report by the British Association for Parenteral and Enteral Nutrition (BAPEN) HOSPITALS, CARE HOMES AND MENTAL HEALTH UNITS NUTRITION
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Medicines concordance and adherence: involving adults and carers in decisions about prescribed medicines 1.1 Short title Medicines
More informationImpact of an Innovative ADC System on Medication Administration
Impact of an Innovative ADC System on Medication Administration March 1, 2016 Nilesh Desai, BS, RPh, MBA Administrator Pharmacy and Clinical Operations Hackensack University Medical Center Conflict of
More informationOutpatient management of community acquired pneumonia
Outpatient management of community acquired pneumonia Wei Shen Lim Consultant Respiratory Physician Honorary Professor of Medicine (University of Nottingham) Nottingham University Hospitals NHS Trust What
More informationPolicy on Learning from Deaths
Trust Policy Policy on Learning from Deaths Key Points Mortality review is an important part of our Safety and Quality Improvement Process. All patients who die in our trust have a review of their care.
More informationSetting The economic study was conducted in a large teaching hospital in Amsterdam, the Netherlands.
Early switch from intravenous to oral antibiotics: guidelines and implementation in a large teaching hospital Sevinc F, Prins J M, Koopmans R P, Langendijk P N, Bossuyt P M, Dankert J, Speelman P Record
More informationIntroduction. Singapore and its Quality and Patient Safety Position. Singapore 2004: Top 5 Key Risk Factors. High Body Mass
Introduction Singapore and its Quality and Patient Safety Position Singapore 2004: Top 5 Key Risk Factors High Body Mass (11.1%; 45,000) Physical Inactivity (3.8%; 15,000) Cigarette Smoking (7.4%; 28,000)
More informationHospital at home or acute hospital care: a cost minimisation analysis Coast J, Richards S H, Peters T J, Gunnell D J, Darlow M, Pounsford J
Hospital at home or acute hospital care: a cost minimisation analysis Coast J, Richards S H, Peters T J, Gunnell D J, Darlow M, Pounsford J Record Status This is a critical abstract of an economic evaluation
More informationPharmacy Services in the Emergency Department
Pharmacy Services in the Emergency Department Targeting the Highest Risk Patients Kunal Gohil Specialist Clinical Pharmacist Emergency Department Nottingham University Hospitals NHS Trust When all else
More informationCHAPTER 9 PERFORMANCE IMPROVEMENT HOSPITAL
CHAPTER 9 PERFORMANCE IMPROVEMENT HOSPITAL PERFORMANCE IMPROVEMENT Introduction to terminology and requirements Performance Improvement Required (Board of Pharmacy CQI program, The Joint Commission, CMS
More informationIntroductions. Welcome to the APAC Global Trigger Tool Session. Dr Carol Haraden IHI Gillian Robb CMDHB. Carol Haraden.
Welcome to the APAC Global Trigger Tool Session Dr Carol Haraden IHI Gillian Robb CMDHB Carol Haraden Introductions Gillian Robb Outline for this session Introduction to the Global Trigger Tool What is
More informationIndicators and descriptors and how they can be used. Hanne Herborg Director R&D Danish College of Pharmacy Practice
Indicators and descriptors and how they can be used Hanne Herborg Director R&D Danish College of Pharmacy Practice Focus - inspiration for workshop discussions The need for development of performance
More informationWHO Programme for International Drug Monitoring, Pharmacovigilance Centres & Patient Safety
WHO Programme for International Drug Monitoring, Pharmacovigilance Centres & Patient Safety Birth of WHO Drug Monitoring Programme Thalidomide Phocomelia 2 16th World Health Assembly 1963 Assembly Resolution
More informationMedicine Reconciliation FREQUENTLY ASKED QUESTIONS NATIONAL MEDICATION SAFETY PROGRAMME
Medicine Reconciliation FREQUENTLY ASKED QUESTIONS NATIONAL MEDICATION SAFETY PROGRAMME The Process What is medicine reconciliation? Medicine reconciliation is an evidence-based process, which has been
More informationTo Dip or Not To Dip
To Dip or Not To Dip a patient centred approach to improve the management of UTI in the Care Home environment FIS 30 th November 2017 #ToDipOrNotToDip #FIS17 Elizabeth Beech on behalf of colleagues National
More informationHome administration of intravenous diuretics to heart failure patients:
Quality and Productivity: Proposed Case Study Home administration of intravenous diuretics to heart failure patients: Increasing productivity and improving quality of care Provided by: British Heart Foundation
More informationA Network of Long Term Care Facilities for Conducting Pharmaco-Epi Observational Studies: Experience from USA and Europe
A Network of Long Term Care Facilities for Conducting Pharmaco-Epi Observational Studies: Experience from USA and Europe Vincent Mor, Ph.D. Giovanni Gambassi, M.D. 1 Conflicts of Interest -- Mor F PI of
More informationTackling the challenge of non-adherence
Tackling the challenge of non-adherence 2 How is adherence defined? WHO definition: the extent to which a person s behaviour taking medication, following a diet and/or executing lifestyle changes corresponds
More informationSame day emergency care: clinical definition, patient selection and metrics
Ambulatory emergency care guide Same day emergency care: clinical definition, patient selection and metrics Published by NHS Improvement and the Ambulatory Emergency Care Network June 2018 Contents 1.
More informationPatient Falls Metric (2018)
Patient Falls Metric (2018) Falls Unintentionally coming to rest on the ground, floor or other lower surface (NPSA 2010) Include all slips, trips and falls e.g. if a patient is found on the floor, lowered
More informationMoving the Green Medicines Bag from the Safety Agenda to QIPP
Moving the Green Medicines Bag from the Safety Agenda to QIPP Jane Hough (ESEE Specialist Pharmacy Services) Fiona Eccleston (PSF Project Manager) Ed England ( Ambulance Service) Facts and figures 97%
More informationReducing Variation in Primary Care Strategy
Reducing Variation in Primary Care Strategy September 2014 Page 1 of 14 REDUCING VARIATION IN PRIMARY CARE STRATEGY 1. Introduction The Reducing Variation in Primary Care Strategy should be seen as one
More informationNursing homes: a case study of prescribing in older people. Carmel M. Hughes
Nursing homes: a case study of prescribing in older people Carmel M. Hughes Objectives of lecture To highlight issues with nursing home care, focussing on use of medicines To highlight influences on prescribing
More informationNational Health Promotion in Hospitals Audit
National Health Promotion in Hospitals Audit Acute & Specialist Trusts Final Report 2012 www.nhphaudit.org This report was compiled and written by: Mr Steven Knuckey, NHPHA Lead Ms Katherine Lewis, NHPHA
More informationExploring the cost of care at the end of life
1 Chris Newdick and Judith Smith, November 2010 Exploring the cost of care at the end of life Research report Theo Georghiou and Martin Bardsley September 2014 The quality of care received by people at
More informationMaryland Patient Safety Center s Annual MEDSAFE Conference: Taking Charge of Your Medication Safety Challenges November 3, 2011 The Conference Center
Maryland Patient Safety Center s Annual MEDSAFE Conference: Taking Charge of Your Medication Safety Challenges November 3, 2011 The Conference Center at the Maritime Institute Reducing Hospital Readmissions
More informationVolume 15 - Issue 2, Management Matrix
Volume 15 - Issue 2, 2015 - Management Matrix Leadership in Healthcare: A Review of the Evidence Prof. Michael West ******@***lancaster.ac.uk Professor - Lancaster University Thomas West ******@***aston.ac.uk
More informationResults of censuses of Independent Hospices & NHS Palliative Care Providers
Results of censuses of Independent Hospices & NHS Palliative Care Providers 2008 END OF LIFE CARE HELPING THE NATION SPEND WISELY The National Audit Office scrutinises public spending on behalf of Parliament.
More informationImproving the reporting of medication-related safety incidents
Rationale Improving the reporting of medication-related safety incidents Research shows that organisations which regularly report more patient safety incidents usually have a stronger learning culture
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Single Technology Appraisal (STA)
Thank you for agreeing to give us a statement on your organisation s view of the technology and the way it should be used in the NHS. Healthcare professionals can provide a unique perspective on the technology
More informationThe PCT Guide to Applying the 10 High Impact Changes
The PCT Guide to Applying the 10 High Impact Changes This Guide has been produced by the NHS Modernisation Agency. For further information on the Agency or the 10 High Impact Changes please visit www.modern.nhs.uk
More informationPredict, prevent & manage AKI: A UK collaboration to detect a devastating condition AKI
Predict, prevent & manage AKI: A UK collaboration to detect a devastating condition AKI Case Study Acute kidney injury (AKI) is a potentially devastating condition, thought to contribute to the deaths
More informationROTATION DESCRIPTION - PGY1 Adult Internal Medicine
ROTATION DESCRIPTION - PGY1 Adult Internal Medicine PURPOSE The IM rotation provides the opportunity for PGY1 residents to improve their knowledge base and pharmacotherapeutic skills while enhancing care
More informationType of intervention Secondary prevention of heart failure (HF)-related events in patients at risk of HF.
Emergency department observation of heart failure: preliminary analysis of safety and cost Storrow A B, Collins S P, Lyons M S, Wagoner L E, Gibler W B, Lindsell C J Record Status This is a critical abstract
More informationMEDICARE CCLF ANALYTICS: MEDICARE ANALYTICS DATA ENGINE (MADE)
MEDICARE CCLF ANALYTICS: MEDICARE ANALYTICS DATA ENGINE (MADE) Frequently Asked Questions 1.0 October 10, 2017 hmetrix hmetrix This document contains frequently asked questions regarding the utility, functionality,
More informationAntibiotic Use and Resistance in Nursing Homes
Antibiotic Use and Resistance in Nursing Homes GHINWA DUMYATI, MD PROFESSOR OF MEDICINE CENTER FOR COMMUNITY HEALTH UNIVERSITY OF ROCHESTER MEDICAL CENTER FEBRUARY 8, 2017 Nicolle LE, et al. Antimicrobial
More informationExpert Rev. Pharmacoeconomics Outcomes Res. 2(1), (2002)
Expert Rev. Pharmacoeconomics Outcomes Res. 2(1), 29-33 (2002) Microcosting versus DRGs in the provision of cost estimates for use in pharmacoeconomic evaluation Adrienne Heerey,Bernie McGowan, Mairin
More informationMy Discharge a proactive case management for discharging patients with dementia
Shine 2013 final report Project title My Discharge a proactive case management for discharging patients with dementia Organisation name Royal Free London NHS foundation rust Project completion: March 2014
More informationCare Home support and medicines optimisation: Community Pharmacy National Enhanced Service
Care Home support and medicines optimisation: Community Pharmacy National Enhanced Service 1 1. Introduction Back in 2006 the National Service Framework for Older People in Wales 1 highlighted the problem
More informationMonthly and Quarterly Activity Returns Statistics Consultation
Monthly and Quarterly Activity Returns Statistics Consultation Monthly and Quarterly Activity Returns Statistics Consultation Version number: 1 First published: 08/02/2018 Prepared by: Classification:
More informationUKMi and Medicines Optimisation in England A Consultation
UKMi and Medicines Optimisation in England A Consultation Executive Summary Medicines optimisation is an approach that seeks to maximise the beneficial clinical outcomes for patients from medicines with
More informationExperience of inpatients with ulcerative colitis throughout
Experience of inpatients with ulcerative colitis throughout the UK UK inflammatory bowel disease (IBD) audit Executive summary report June 2014 Prepared by the Clinical Effectiveness and Evaluation Unit
More informationNational Mortality Case Record Review Programme. Using the structured judgement review method A guide for reviewers (England)
National Mortality Case Record Review Programme Using the structured judgement review method A guide for reviewers (England) Supported by: Commissioned by: Dr Allen Hutchinson Emeritus professor in public
More informationScottish Hospital Standardised Mortality Ratio (HSMR)
` 2016 Scottish Hospital Standardised Mortality Ratio (HSMR) Methodology & Specification Document Page 1 of 14 Document Control Version 0.1 Date Issued July 2016 Author(s) Quality Indicators Team Comments
More informationThe Primary Care Trigger Tool: Practical Guidance
The Primary Care Trigger Tool: Practical Guidance Reviewing clinical records to detect and reduce patient safety incidents Index Content Page Introduction 2 What is a Trigger Tool Review? 2 What types
More informationA Resident-led PICU Morbidity and Mortality Conference
A Resident-led PICU Morbidity and Mortality Conference James Moses, MD, MPH Associate Program Director Boston Combined Residency Program Director of Patient Safety and Quality Department of Pediatrics
More informationStudy population The study population comprised patients requesting same day appointments between 8:30 a.m. and 5 p.m.
Nurse telephone triage for same day appointments in general practice: multiple interrupted time series trial of effect on workload and costs Richards D A, Meakins J, Tawfik J, Godfrey L, Dutton E, Richardson
More informationCorporate Induction: Part 2
Corporate Induction: Part 2 Identification of preventable Adverse Drug Reactions from a regulatory perspective March 1 st 2013, EMA Workshop on Medication Errors Presented by Almath Spooner, Pharmacovigilance
More informationCommissioning a Community IV service
East & outh East England pecialist Pharmacy ervices East of England, London, outh Central & outh East Coast Medicines Use and afety Commissioning a Community IV service East and outh East of England pecialist
More informationCommunity Performance Report
: Wenatchee Current Year: Q1 217 through Q4 217 Qualis Health Communities for Safer Transitions of Care Performance Report : Wenatchee Includes Data Through: Q4 217 Report Created: May 3, 218 Purpose of
More informationFrequently Asked Questions (FAQ) Updated September 2007
Frequently Asked Questions (FAQ) Updated September 2007 This document answers the most frequently asked questions posed by participating organizations since the first HSMR reports were sent. The questions
More informationThe Bullous Pemphigoid Steroids And Tetracyclines (BLISTER) Study. Health Economics Analysis Plan V1.1 3 rd March 2014
The Bullous Pemphigoid Steroids And Tetracyclines (BLISTER) Study Health Economics Analysis Plan V1.1 3 rd March 2014 Study No: UKCRN ID2611 EUDRACT: 2007-006658-24 ISRCTN: ISRCTN13704604 Funded by: NIHR
More informationVersion 2 15/12/2013
The METHOD study 1 15/12/2013 The Medical Emergency Team: Hospital Outcomes after a Day (METHOD) study Version 2 15/12/2013 The METHOD Study Investigators: Principal Investigator Christian P Subbe, Consultant
More informationImproving patient safety and infection. Patient Safety Forum Dr J Coleman 1 ELECTRONIC PRESCRIBING AND CLINICAL DECISION SUPPORT (CDS)
Improving Patient Safety and Infection Control Through Electronic Prescribing Dr Jamie Coleman Senior Lecturer in Clinical Pharmacology / Honorary Consultant Physician The brief Clinical computing technologies
More informationBackground and Methodology
Study Sites and Investigators Emergency Department Pharmacists Improve Patient Safety: Results of a Multicenter Study Supported by the ASHP Foundation Jeffrey Rothschild, MD, MPH-Principal Investigator
More informationUsing the structured judgement review method
National Mortality Case Record Review Programme Using the structured judgement review method A clinical governance guide to mortality case record reviews Supported by: Commissioned by: Dr Andrew Gibson
More informationRCN advisor Amanda Cheesley (2012) in a statement about cuts and lack of development of specialist nursing posts stated;
Children s Continence Service An Affordable Luxury? RCN advisor Amanda Cheesley (2012) in a statement about cuts and lack of development of specialist nursing posts stated; they (specialist nurses) are
More informationMaking it safe for acutely ill patients - a whistlestop tour of medical error & patient harm
Making it safe for acutely ill patients - a whistlestop tour of medical error & patient harm Sara Barton Acute Physician Salford Royal NHS Foundation Trust What is medical error? Medical errors can be
More informationMedications: Defining the Role and Responsibility of Physical Therapy Practice
This article is based on a presentation by Matt Janes, PT, DPT, MHS, OCS, CSCS, Division AVP, Therapy Practice and Quality, Kindred at Home, and Diana Kornetti, PT, MA, HCS-D, President, Home Health Section
More informationAdverse Drug Events and Readmissions: The Global Picture
Adverse Drug Events and Readmissions: The Global Picture Kyle E. Hultgren, PharmD Managing Director Center for Medication Safety Advancement Purdue University College of Pharmacy Indianapolis, IN 4 Learning
More informationGovernance in action the first year of the National Standards Victorian Healthcare Quality Association. 25 October, 2013
Governance in action the first year of the National Standards Victorian Healthcare Quality Association 25 October, 2013 Overview Clinical governance: what is it? whose responsibility? Elements of a governance
More informationLearning from Deaths Policy
Learning from Deaths Policy Version: 3 Approved by: Board of Directors Date Approved: October 2017 Lead Manager: Associate Medical Director for Patient Safety and Clinical Risk Responsible Director: Medical
More informationCaregiving time costs and trade-offs with paid work and leisure: Evidence from Sweden, UK and Canada Extended abstract
Caregiving time costs and trade-offs with paid work and leisure: Evidence from Sweden, UK and Canada Maria Stanfors* & Josephine Jacobs** & Jeffrey Neilson* *Centre for Economic Demography Lund University,
More informationPharmacists Role in Care Transitions
Pharmacists Role in Care Transitions SHE A FA NNING, PHA RMD, PGY 1 PHA RMA C Y RE SIDENT ST. PETER S HOSPITAL HE LE NA, MT Disclosures Co-investigators: Thomas Richardson, PharmD, BCPS AQ-ID; Brad Hornung,
More informationBurden of MRSA Colonization in Elderly Residents of Nursing Homes: A Systematic Review and Meta Analysis
Burden of MRSA Colonization in Elderly Residents of Nursing Homes: A Systematic Review and Meta Analysis Monika Pogorzelska-Maziarz, MPH, PhD Thomas Jefferson University, Jefferson School of Nursing Philadelphia,
More informationICU Research Using Administrative Databases: What It s Good For, How to Use It
ICU Research Using Administrative Databases: What It s Good For, How to Use It Allan Garland, MD, MA Associate Professor of Medicine and Community Health Sciences University of Manitoba None Disclosures
More informationThe attitude of nurses towards inpatient aggression in psychiatric care Jansen, Gradus
University of Groningen The attitude of nurses towards inpatient aggression in psychiatric care Jansen, Gradus IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you
More informationPreventable Patient Harm across Health Care Services: A Systematic Review and Meta-analysis
Preventable Patient Harm across Health Care Services: A Systematic Review and Meta-analysis (Understanding Harmful Care) A report for the General Medical Council July 2017 Dr Maria Panagioti*, 1,2 Ms Kanza
More informationMEDICARE CCLF ANALYTICS: MEDICARE ANALYTICS DATA ENGINE (MADE)
MEDICARE CCLF ANALYTICS: MEDICARE ANALYTICS DATA ENGINE (MADE) Frequently Asked Questions 1.2 November 13, 2017 hmetrix hmetrix This document contains frequently asked questions regarding the utility,
More informationPHARMACY SERVICES/MEDICATION USE
25.01. 10 Drug Reactions & Administration Errors & Incompatibilities. Drug administration errors, adverse drug reactions and incompatibilities must be immediately reported to the attending physician and
More informationEffectively implementing multidisciplinary. population segments. A rapid review of existing evidence
Effectively implementing multidisciplinary teams focused on population segments A rapid review of existing evidence October 2016 Francesca White, Daniel Heller, Cait Kielty-Adey Overview This review was
More informationQuality Assessment and Performance Improvement in the Ophthalmic ASC
Quality Assessment and Performance Improvement in the Ophthalmic ASC ELETHIA DEAN RN,BSN, MBA, PHD Regulatory Requirements QAPI Program required by: Medicare Most states ASC licensing regulations Accrediting
More informationMeasuring Harm. Objectives and Overview
Patient Safety Research Introductory Course Session 3 Measuring Harm Albert W Wu, MD, MPH Former Senior Adviser, WHO Professor of Health Policy & Management, Johns Hopkins Bloomberg School of Public Health
More informationPatient Safety Research Introductory Course Session 3. Measuring Harm
Patient Safety Research Introductory Course Session 3 Measuring Harm Albert W Wu, MD, MPH Former Senior Adviser, WHO Professor of Health Policy & Management, Johns Hopkins Bloomberg School of Public Health
More informationClinical Practice Guideline Development Manual
Clinical Practice Guideline Development Manual Publication Date: September 2016 Review Date: September 2021 Table of Contents 1. Background... 3 2. NICE accreditation... 3 3. Patient Involvement... 3 4.
More informationPreventing In-Facility Falls
Preventing In-Facility Falls Presented by Paul Shekelle, M.D., Ph.D. RAND Corporation Evidence-based Practice Center Introduction: Making Health Care Safer II: An Updated Critical Analysis of the Evidence
More informationImproving Quality of Life of Long-Term Patient - From the Community Perspective
Improving Quality of Life of Long-Term Patient - From the Community Perspective Dr Caz Sayer, Camden CCG Chair Working with the people of Camden to achieve the best health for all Context The Health and
More informationAccess to Health Care Services in Canada, 2003
Access to Health Care Services in Canada, 2003 by Claudia Sanmartin, François Gendron, Jean-Marie Berthelot and Kellie Murphy Health Analysis and Measurement Group Statistics Canada Statistics Canada Health
More informationQuality and Leadership: Improving outcomes
Quality and Leadership: Improving outcomes Podiatry Managers/Allied Health Managers and Leaders 5 March 2014 Shelagh Morris OBE Acting Chief Allied Health Professions Officer 2 http://www.nhsemployers.org/aboutus/latest-news/pages/the-new-nhs-in-2013-infographic.aspx
More information